|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 237.00 EUR | -1.37% |
|
+1.24% | -0.67% |
| 05-12 | H Lundbeck raises 2026 forecasts on US demand, delayed generic competition | RE |
| 05-07 | UCB: New partnership with Cancer Research UK and Cancer Research Horizons | RE |
| Capitalization | 45.12B 52.43B 41.25B 39.36B 72.15B 5,030B 73.34B 495B 192B 2,388B 197B 193B 8,319B | P/E ratio 2026 * |
25.7x | P/E ratio 2027 * | 19.8x |
|---|---|---|---|---|---|
| Enterprise value | 43.63B 50.7B 39.89B 38.06B 69.77B 4,864B 70.93B 479B 185B 2,309B 190B 186B 8,045B | EV / Sales 2026 * |
5.16x | EV / Sales 2027 * | 4.37x |
| Free-Float |
61.59% | Yield 2026 * |
0.62% | Yield 2027 * | 0.63% |
Last Transcript: UCB
Trading UCB
| 1 day | -1.37% | ||
| 1 week | +1.24% | ||
| Current month | +2.51% | ||
| 1 month | -8.39% | ||
| 3 months | -15.57% | ||
| 6 months | +4.45% | ||
| Current year | -0.67% |
| 1 week | 232.2 |  | 243 |
| 1 month | 223 | | 261.5 |
| Current year | 223 | | 289.5 |
| 1 year | 152.95 | | 289.5 |
| 3 years | 65.4 | | 289.5 |
| 5 years | 65.4 | | 289.5 |
| 10 years | 54.84 | | 289.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 31/12/2014 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 30/06/2020 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 30/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 27/04/2016 | |
Dame Davies
BRD | Director/Board Member | 75 | 31/12/2013 |
| Director/Board Member | 67 | 31/12/2014 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +5.66% | 0.42% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.37% | +1.24% | +49.48% | +177.52% | 52.43B | |
| -2.05% | -2.33% | +17.49% | -5.93% | 71.04B | |
| -2.07% | +41.90% | +41.90% | +41.90% | 43.84B | |
| +0.72% | -18.28% | -59.49% | -67.80% | 33.99B | |
| +0.83% | -0.26% | +53.63% | -37.27% | 28.49B | |
| -1.98% | -9.77% | +97.26% | -60.80% | 19.46B | |
| -2.38% | -3.30% | +50.54% | +47.31% | 19.04B | |
| -5.42% | -8.89% | +60.78% | +102.47% | 18.17B | |
| +0.55% | +1.33% | +43.37% | +87.50% | 16.16B | |
| -4.16% | +8.37% | +16.22% | +744.39% | 13.18B | |
| Average | -1.73% | -2.94% | +37.12% | +102.93% | 31.58B | |
| Weighted average by Cap. | -1.55% | -3.36% | +31.84% | +63.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.46B 9.83B 7.73B 7.38B 13.53B 943B 13.75B 92.77B 35.9B 448B 36.88B 36.09B 1,560B | 9.53B 11.08B 8.72B 8.32B 15.24B 1,063B 15.5B 105B 40.46B 504B 41.57B 40.68B 1,758B |
| Net income | 1.76B 2.05B 1.61B 1.54B 2.82B 197B 2.87B 19.34B 7.48B 93.3B 7.69B 7.52B 325B | 2.26B 2.63B 2.07B 1.98B 3.62B 253B 3.68B 24.84B 9.61B 120B 9.88B 9.67B 418B |
| Net Debt | -1.49B -1.73B -1.36B -1.3B -2.38B -166B -2.42B -16.31B -6.31B -78.7B -6.48B -6.35B -274B | -3.43B -3.98B -3.13B -2.99B -5.48B -382B -5.57B -37.57B -14.54B -181B -14.94B -14.62B -632B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/05/26 | 237.00 € | -1.37% | 151,927 |
| 14/05/26 | 240.30 € | +0.50% | 108,633 |
| 13/05/26 | 239.10 € | -0.91% | 190,962 |
| 12/05/26 | 241.30 € | +2.33% | 243,958 |
| 11/05/26 | 235.80 € | +0.73% | 169,265 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- UCB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition